Heart transplantation in Vienna: 25 Years of experience

被引：0

作者：

Zuckermann A. ^{[1
,2
]}

Aliabadi A. ^{[1
]}

Dunkler D. ^{[1
]}

Mahr S. ^{[1
]}

Grömmer M. ^{[1
]}

Zimpfer D. ^{[1
]}

Bunzel B. ^{[1
]}

Rajek A. ^{[1
]}

Wieselthaler G. ^{[1
]}

Hülsmann M. ^{[1
]}

Pacher R. ^{[1
]}

Wollenek G. ^{[1
]}

Weigel G. ^{[1
]}

Salzer-Muhar U. ^{[1
]}

Laczkovics A. ^{[1
]}

Laufer G. ^{[1
]}

Grimm M. ^{[1
]}

Wolner E. ^{[1
]}

机构：

[1] Department of Cardio-Thoracic Surgery, Department of Cardio-Thoracic Anesthesiology and Intensive Care, Medical University of Vienna

[2] Department of Cardiothoracic Surgery, University of Vienna, 1090 Vienna

来源：

Wiener klinische Wochenschrift | 2008年 / 120卷 / Suppl 2期

关键词：

Acute Rejection; Heart Transplantation; Cardiac Transplantation; Neopterin; Heart Transplant Recipient;

D O I：

10.1007/s00508-008-1042-1

中图分类号：

学科分类号：

摘要：

Since the beginning of the University of Vienna Cardiac Transplant Program in 1984, 1113 heart transplant procedures have been performed through August of 2008. One- and five-year survival has increased steadily over time (82% and 76%). Ten-year survival is 65%. Over the past 25 years our program has seen dramatic changes in patient selection, accepting now patients with more risk factors (e.g. age, diabetes, elevated pulmonary resistance). Developments in immunosuppression have decreased incidence of infection, rejection and graftarteriosclerosis continuously. Our program continues to pursue novel strategies to improve the survival and quality of life of our heart transplant patients. © 2008 Springer-Verlag.

引用

页码：3 / 10

页数：7

共 82 条

[1]

Laczkovics A., Havel M., Laufer G., Teufelsbauer H., Gollner C., Wolner E., Orthotopic heart transplantation - Experiences at the University Surgical Clinic II in Vienna (status: June 1986), Wien Klin Wochenschr, 99, pp. 333-340, (1987)

[2]

Woloszczuk W., Schwarz M., Havel M., Laczkovics A., Muller M.M., Neopterin and interferon gamma serum levels in patients with heart and kidney transplants, J Clin Chem Clin Biochem, 24, pp. 729-734, (1986)

[3]

Hamilton G., Roth E., Muhlbacher F., Funovics J., Piza F., Schindler J., Et al., Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation, Wien Klin Wochenschr, 98, pp. 820-824, (1986)

[4]

Havel M.P., Laczkovics A.M., Kurz R.W., Muller M.M., Wolner E., Neopterin as a parameter for the early detection of acute graft rejection following heart transplantation, Z Med Lab Diagn, 28, pp. 429-435, (1987)

[5]

Hamilton G., Muhlbacher F., Roth E., Wolf I., Piza F., Havel M., Et al., Comparison of cyclosporine a dosage and metabolism in liver and heart transplant recipients, Transplant Proc, 19, pp. 1706-1708, (1987)

[6]

Trubel W., Losert U., Schima H., Rokitansky A., Spiss C.K., Coraim F., Et al., Total artificial heart bridging: A temporary support for deteriorating heart transplantation-candidates - Methods and results, Thorac Cardiovasc Surg, 35, pp. 277-282, (1987)

[7]

Laufer G., Laczkovics A., Wollenek G., Schreiner W., Wolner E., Results of orthotopic heart transplantation with and without the use of maintenance steroids, Eur J Cardiothorac Surg, 2, pp. 237-243, (1988)

[8]

Laufer G., Laczkovics A., Wollenek G., Schreiner W., Kober I., Wolner E., Incidence and severity of acute cardiac allograft rejection with two different low-dose cyclosporine maintenance protocols, Ann Thorac Surg, 46, pp. 382-388, (1988)

[9]

Wollenek G., Laufer G., Laczkovics A., Buxbaum P., Kober I., Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation, Transplant Proc, 21, pp. 2499-2501, (1989)

[10]

Laufer G., Laczkovics A., Wollenek G., Schreiner W., Sochor H., Holzinger C., Et al., Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts, J Heart Transplant, 8, pp. 253-261, (1989)

← 1 2 3 4 5 6 7 8 9 →